Clin2
NCT06292494Possibly a fitRecruiting

Focused ultrasound for drug-resistant epilepsy

Focused UltrasoundMR-guided FUSDrug Refractory EpilepsyDrug Resistant EpilepsyMedication Resistant Epilepsy

Part of Brain & nervous system clinical trials.

This trial tests a treatment called focused ultrasound, which uses sound waves to target and help control seizures in people whose epilepsy has not improved with at least two medications. It may offer a new option for those with localized epilepsy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • Your epilepsy must not be controlled by two or more seizure medications.
  • You need to have records of your seizures for at least one month before the trial.
  • You must have had a full check-up including EEG, MRI, and PET scans.
  • You must be able to have an MRI and a CT scan, and your skull density must meet a certain level.
  • You must be able to communicate during the procedure and press a stop button if needed.
  • You must be willing to have hair removed from the treatment area.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06492720Recruiting
Testing focused ultrasound for drug-resistant epilepsy

This study tests a new device called NaviFUS that uses focused sound waves to gently stimulate a small area of the brain. It is for people whose seizures start in one part of the brain and are not fully controlled by seizure medicines.

Taipei
NCT07497178Not yet recruiting
Focused ultrasound for epilepsy in children

This trial tests a non-invasive procedure called magnetic resonance-guided focused ultrasound (MRgFUS) to treat epilepsy caused by brain lesions in children. This approach uses sound waves to target and destroy the lesion without surgery, which may reduce seizures.

NCT07680842Recruiting
Non-invasive ultrasound for drug-resistant epilepsy

This study tests a non-invasive focused ultrasound treatment for people with epilepsy that doesn't respond to medications. The goal is to see if this gentle ultrasound can reduce seizures without surgery.

San Francisco, California
NCT03868293Recruiting
Low-intensity ultrasound for drug-resistant temporal lobe seizures

This pilot study tests whether low-intensity focused ultrasound can reduce seizures in adults whose temporal lobe epilepsy hasn’t improved with at least two anti-seizure medicines. You may be asked to track seizure timing and undergo brain imaging before and during the study.

Boston, Massachusetts
NCT06388707Recruiting· Phase 1/Phase 2
Ultrasound therapy for drug-resistant temporal lobe epilepsy

This study tests if a new, non-invasive ultrasound treatment can safely reduce seizures in people whose seizures start in the temporal lobe and have not been controlled by at least two anti-epileptic drugs. The ultrasound is delivered through the scalp to gently stimulate the brain area where the seizures begin.

Palo Alto, California
NCT07249190Not yet recruiting· Phase 1
Focused ultrasound for drug-resistant epilepsy

This trial tests a non-invasive treatment for hard-to-control epilepsy. Using MRI guidance, sound waves are focused on a small area in the brain to reduce seizures, offering a possible alternative to open surgery.

Hear when a new Focused Ultrasound trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.